Lactoferrin Inhibits the Lipopolysaccharide-Induced Expression and Proteoglycan-Binding Ability of Interleukin-8 in Human Endothelial Cells
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Interleukin-8 (IL-8), a C-X-C chemokine bound to endothelium proteoglycans, initiates the activation and selective recruitment of leukocytes at inflammatory foci. We demonstrate that human lactoferrin, an antimicrobial lipopolysaccharide (LPS)-binding protein, decreases both IL-8 mRNA and protein expression induced by the complex Escherichia coli 055:B5 LPS/sCD14 in human umbilical vein endothelial cells. The use of recombinant lactoferrins mutated in the LPS-binding sites indicates that this inhibitory effect is mediated by an interaction of lactoferrin with LPS and CD14s that suppresses the endotoxin biological activity. Furthermore, since dimeric IL-8 and lactoferrin are both proteoglycan-binding molecules, the competition between these proteins for heparin binding was investigated. Lactoferrin strongly inhibited the interaction of radiolabeled IL-8 to immobilized heparin, whereas a lactoferrin variant lacking the amino acid residues essential for heparin binding was not inhibitory. Moreover, this process is specific, since serum transferrin, a glycoprotein whose structure is close to that of lactoferrin, did not prevent the interaction of IL-8 with heparin. These results suggest that the anti-inflammatory properties of lactoferrin during septicemia are related, at least in part, to the regulation of IL-8 production and also to the ability of lactoferrin to compete with chemokines for their binding to proteoglycans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LACTOFERRIN, AN IRON-BINBING PROTEIN NI NEUTROPHILIC LEUKOCYTES
Masson, P. L., Heremans, J. F., & Schonne, E. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.130.3.643 · Cited by 700
Cited by
Lactoferrin as a natural immune modulator
Actor, J., Hwang, S.-A., & Kruzel, M. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788453202 · Cited by 455
“Specifically, human lactoferrin effectively competes with IL-8 for proteoglycan binding sites, and may serve as an explanation of the anti-inflammatory effects of lactoferrin observed in in vivo sepsis models [203].”
BackgroundLactoferrin: Lactoferrin: a modulator of immune and inflammatory responses
Legrand, D., Elass, E., Carpentier, M., & Mazurier, J. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5370-2 · Cited by 420
Self-citationOverview of Lactoferrin as a Natural Immune Modulator
Legrand, D. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.02.071 · Cited by 296
Self-citationLactoferrin Structure and Functions
Legrand, D., Pierce, A., Elass, E., Carpentier, M., Mariller, C., & Mazurier, J. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-74087-4_6 · Cited by 293
Self-citationLactoferrin Is a Potent Regulator of Bone Cell Activity and Increases Bone Formation in Vivo
Cornish, J., Callon, K. E., Naot, D., Palmano, K. P., Banovic, T., Bava, U., Watson, M., Lin, J.-M., Tong, P. C., Chen, Q., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1307 · Cited by 282
Metadata
- Authors
- Elass, E., Masson, M., Mazurier, J., & Legrand, D.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2002-04
- Volume
- 70
- Issue
- 4
- Pages
- 1860-1866
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W2150624208
- Cited by
- 108
- References
- 1
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lactoferrin Inhibits the Lipopolysaccharide-Induced Expression and Proteoglycan-Binding Ability of Interleukin-8 in Human Endothelial Cells. https://app.cochat.ai/papers/10.1128/iai.70.4.1860-1866.2002
- The paper
- Elass, E., Masson, M., Mazurier, J., & Legrand, D. (2002). Lactoferrin Inhibits the Lipopolysaccharide-Induced Expression and Proteoglycan-Binding Ability of Interleukin-8 in Human Endothelial Cells. Infection and Immunity. https://doi.org/10.1128/iai.70.4.1860-1866.2002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.